The landscape of public health in India is marked by a high burden of vector-borne diseases (VBDs), which are a major cause of morbidity and mortality. This article aims to provide a comprehensive review of the prevalence and management of VBDs in India, focusing on diseases such as malaria, dengue, and chikungunya.
India carries a significant burden of VBDs. Malaria, for instance, is endemic in most of the country, with rural and tribal areas being the most affected. Dengue, on the other hand, has emerged as a major public health concern over the last few decades, with urban and semi-urban areas witnessing a surge in cases. Chikungunya, although less prevalent than malaria and dengue, has caused significant outbreaks in several states.
The management of VBDs in India involves a multipronged strategy that includes prevention, early detection, and treatment. Prevention strategies primarily involve vector control measures, such as the use of insecticide-treated nets and indoor residual spraying. Early diagnosis and prompt treatment are crucial for reducing morbidity and preventing complications. The National Vector Borne Disease Control Programme (NVBDCP) plays a pivotal role in the management of VBDs in India, providing guidelines and resources for prevention, diagnosis, and treatment.
The management of VBDs in India faces several challenges, including a lack of awareness, inadequate healthcare infrastructure, and resistance to insecticides. Future efforts should focus on strengthening disease surveillance, improving diagnostic facilities, and enhancing community participation in vector control activities. Research into new vector control methods and treatments is also crucial.
Understanding the prevalence and management of VBDs is critical for healthcare professionals in India. Despite the challenges, significant progress has been made in controlling these diseases. However, sustained efforts are required to further reduce the burden of VBDs and improve public health in India.
1.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
2.
Nodal Response After Chemo Helps Tailor Breast Radiotherapy
3.
For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.
4.
In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.
5.
Common intracellular toxin could help fight leukemia
1.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
2.
Clonal Hematopoiesis and Thrombotic Risk Beyond Cancer: A Comprehensive Review for Clinicians
3.
Unlocking The Causes And Risk Factors Of Breast Cancer
4.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
5.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Thromboprophylaxis In Medical Settings
2.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
3.
How Multidisciplinary Teams Support Modern Cancer Care
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation